Literature DB >> 16480147

The library of human miniantibodies in the phage display format: designing and testing.

A B Ulitin1, M V Kapralova, A G Laman, A O Shepelyakovskaya, E V Bulgakova, K K Fursova, S G Abbasova, S K Volkov, F A Brovko, V A Nesmeyanov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16480147     DOI： 10.1007/s10628-005-0134-3

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  14 in total

1.  A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies.

Authors:  H J de Haard; N van Neer; A Reurs; S E Hufton; R C Roovers; P Henderikx; A P de Bruïne; J W Arends; H R Hoogenboom
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

2.  Generation of a large complex antibody library from multiple donors.

Authors:  M Little; M Welschof; M Braunagel; I Hermes; C Christ; A Keller; P Rohrbach; T Kürschner; S Schmidt; C Kleist; P Terness
Journal:  J Immunol Methods       Date:  1999-12-10       Impact factor: 2.303

Review 3.  Antibodies from phage antibody libraries.

Authors:  Andrew R M Bradbury; James D Marks
Journal:  J Immunol Methods       Date:  2004-07       Impact factor: 2.303

4.  Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire.

Authors:  R M de Wildt; R M Hoet; W J van Venrooij; I M Tomlinson; G Winter
Journal:  J Mol Biol       Date:  1999-01-22       Impact factor: 5.469

5.  Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens.

Authors:  M D Sheets; P Amersdorfer; R Finnern; P Sargent; E Lindquist; R Schier; G Hemingsen; C Wong; J C Gerhart; J D Marks; E Lindqvist
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 6.  Design and application of diabodies, triabodies and tetrabodies for cancer targeting.

Authors:  A Todorovska; R C Roovers; O Dolezal; A A Kortt; H R Hoogenboom; P J Hudson
Journal:  J Immunol Methods       Date:  2001-02-01       Impact factor: 2.303

Review 7.  Monoclonal antibodies combined to chemotherapy for the treatment of patients with lymphoma.

Authors:  Bertrand Coiffier
Journal:  Blood Rev       Date:  2003-03       Impact factor: 8.250

Review 8.  Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors.

Authors:  Winfried Wels; Markus Biburger; Tina Müller; Benjamin Dälken; Ulrike Giesübel; Torsten Tonn; Christoph Uherek
Journal:  Cancer Immunol Immunother       Date:  2003-12-24       Impact factor: 6.968

9.  Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library.

Authors:  T J Vaughan; A J Williams; K Pritchard; J K Osbourn; A R Pope; J C Earnshaw; J McCafferty; R A Hodits; J Wilton; K S Johnson
Journal:  Nat Biotechnol       Date:  1996-03       Impact factor: 54.908

10.  Isolation of high affinity human antibodies directly from large synthetic repertoires.

Authors:  A D Griffiths; S C Williams; O Hartley; I M Tomlinson; P Waterhouse; W L Crosby; R E Kontermann; P T Jones; N M Low; T J Allison
Journal:  EMBO J       Date:  1994-07-15       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.